{
  "drug_name": "Crotalidae_polyvalent_immune_Fab_(Crofab)",
  "url": "https://wikem.org/wiki/Crotalidae_polyvalent_immune_Fab_(Crofab)",
  "scraped_at": "2026-01-10T07:51:13.439531",
  "sections": {
    "Background": {
      "text": "The original Antivenin Crotalidae Polyvalent (ACP)\n[1]\nwas manufactured by Wyeth Pharmaceutical for use in the US but due to severe delayed allergic reactions was discontinued.\nThe FDA approved Crofab, an antivenom derived from sheep serum\n[2]\nin 2000.  The antibodies bind and neutralize venom components.",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Synthesis_and_Production": {
      "text": "Produced from sheep serum after inoculation with venom from:\nEastern diamondback rattlesnake (Crotalus adamants)\nWestern diamondback rattlesnake (Crotalus atria)\nMojave rattlesnake (Crotalus scutulatus).\nCottonmouth (Agkistrodon piscivorus)\nThe Fc portion of the antibody is eliminated after mixture with papain and subsequent purification.",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Indications_for_Administration_of_CroFab": {
      "text": "Progression of swelling\nAbnormal results on lab tests (platelets < 100,000 or fibrinogen < 100)\nSystemic manifestations (unstable vitals or\naltered mental status\n)",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "altered mental status",
          "url": "https://wikem.org/wiki/Altered_mental_status"
        }
      ]
    },
    "Dosing_and_Administration": {
      "text": "",
      "subsections": {
        "Initial_Administration": {
          "text": "Initial dose: 6 vials\n[4]\nTypically diluted into 250 cc or 1 L of normal saline and infused over an hour\nSame dose for both adults and pediatrics (may have to adjust the dilution of CroFab for small children so that they are not volume overloaded)",
          "tables": []
        },
        "Maintenance_therapy": {
          "text": "May repeat dose (2 vials) at 6, 12, and 18 hours later if symptoms not controlled\n[5]\nMaintance therapy may be indicated after initial dosing based on local protocols even if control is achieved.\n[6]",
          "tables": []
        },
        "Envenomation_control_measurement": {
          "text": "Observe for progression of envenomation during and after antivenom infusion\nMeasure limb circumference at several sites above and below bite\nMark advancing border of edema q30min\nRepeat labs q4hr or after each course of antivenom (whichever is more frequent)",
          "tables": []
        },
        "Side_Effects": {
          "text": "Acute\nallergic reactions\noccur in <10% pts\nIf occurs stop infusion and give epinephrine/antihistamines if needed\nRecurrent\nthrombocytopenia\nhas been described up to 2 weeks after transfusion with FabAV and is likely a result of isolated renal clearance of FabAV and persistent presence of actual venom in serum.\n[7]\nWarrants close monitoring of platelets by primary physician or return visit after discharge\nSerum sickness\nis unlikely but precautions should be given to patents upon discharge\nPregnancy category C",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "allergic reactions",
          "url": "https://wikem.org/wiki/Allergic_reactions"
        },
        {
          "text": "thrombocytopenia",
          "url": "https://wikem.org/wiki/Thrombocytopenia"
        },
        {
          "text": "Serum sickness",
          "url": "https://wikem.org/wiki/Serum_sickness"
        }
      ]
    },
    "Initial_Administration": {
      "text": "Initial dose: 6 vials\n[4]\nTypically diluted into 250 cc or 1 L of normal saline and infused over an hour\nSame dose for both adults and pediatrics (may have to adjust the dilution of CroFab for small children so that they are not volume overloaded)",
      "subsections": {
        "Maintenance_therapy": {
          "text": "May repeat dose (2 vials) at 6, 12, and 18 hours later if symptoms not controlled\n[5]\nMaintance therapy may be indicated after initial dosing based on local protocols even if control is achieved.\n[6]",
          "tables": []
        },
        "Envenomation_control_measurement": {
          "text": "Observe for progression of envenomation during and after antivenom infusion\nMeasure limb circumference at several sites above and below bite\nMark advancing border of edema q30min\nRepeat labs q4hr or after each course of antivenom (whichever is more frequent)",
          "tables": []
        },
        "Side_Effects": {
          "text": "Acute\nallergic reactions\noccur in <10% pts\nIf occurs stop infusion and give epinephrine/antihistamines if needed\nRecurrent\nthrombocytopenia\nhas been described up to 2 weeks after transfusion with FabAV and is likely a result of isolated renal clearance of FabAV and persistent presence of actual venom in serum.\n[7]\nWarrants close monitoring of platelets by primary physician or return visit after discharge\nSerum sickness\nis unlikely but precautions should be given to patents upon discharge\nPregnancy category C",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "allergic reactions",
          "url": "https://wikem.org/wiki/Allergic_reactions"
        },
        {
          "text": "thrombocytopenia",
          "url": "https://wikem.org/wiki/Thrombocytopenia"
        },
        {
          "text": "Serum sickness",
          "url": "https://wikem.org/wiki/Serum_sickness"
        }
      ]
    },
    "Maintenance_therapy": {
      "text": "May repeat dose (2 vials) at 6, 12, and 18 hours later if symptoms not controlled\n[5]\nMaintance therapy may be indicated after initial dosing based on local protocols even if control is achieved.\n[6]",
      "subsections": {
        "Envenomation_control_measurement": {
          "text": "Observe for progression of envenomation during and after antivenom infusion\nMeasure limb circumference at several sites above and below bite\nMark advancing border of edema q30min\nRepeat labs q4hr or after each course of antivenom (whichever is more frequent)",
          "tables": []
        },
        "Side_Effects": {
          "text": "Acute\nallergic reactions\noccur in <10% pts\nIf occurs stop infusion and give epinephrine/antihistamines if needed\nRecurrent\nthrombocytopenia\nhas been described up to 2 weeks after transfusion with FabAV and is likely a result of isolated renal clearance of FabAV and persistent presence of actual venom in serum.\n[7]\nWarrants close monitoring of platelets by primary physician or return visit after discharge\nSerum sickness\nis unlikely but precautions should be given to patents upon discharge\nPregnancy category C",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "allergic reactions",
          "url": "https://wikem.org/wiki/Allergic_reactions"
        },
        {
          "text": "thrombocytopenia",
          "url": "https://wikem.org/wiki/Thrombocytopenia"
        },
        {
          "text": "Serum sickness",
          "url": "https://wikem.org/wiki/Serum_sickness"
        }
      ]
    },
    "Envenomation_control_measurement": {
      "text": "Observe for progression of envenomation during and after antivenom infusion\nMeasure limb circumference at several sites above and below bite\nMark advancing border of edema q30min\nRepeat labs q4hr or after each course of antivenom (whichever is more frequent)",
      "subsections": {
        "Side_Effects": {
          "text": "Acute\nallergic reactions\noccur in <10% pts\nIf occurs stop infusion and give epinephrine/antihistamines if needed\nRecurrent\nthrombocytopenia\nhas been described up to 2 weeks after transfusion with FabAV and is likely a result of isolated renal clearance of FabAV and persistent presence of actual venom in serum.\n[7]\nWarrants close monitoring of platelets by primary physician or return visit after discharge\nSerum sickness\nis unlikely but precautions should be given to patents upon discharge\nPregnancy category C",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "allergic reactions",
          "url": "https://wikem.org/wiki/Allergic_reactions"
        },
        {
          "text": "thrombocytopenia",
          "url": "https://wikem.org/wiki/Thrombocytopenia"
        },
        {
          "text": "Serum sickness",
          "url": "https://wikem.org/wiki/Serum_sickness"
        }
      ]
    },
    "Side_Effects": {
      "text": "Acute\nallergic reactions\noccur in <10% pts\nIf occurs stop infusion and give epinephrine/antihistamines if needed\nRecurrent\nthrombocytopenia\nhas been described up to 2 weeks after transfusion with FabAV and is likely a result of isolated renal clearance of FabAV and persistent presence of actual venom in serum.\n[7]\nWarrants close monitoring of platelets by primary physician or return visit after discharge\nSerum sickness\nis unlikely but precautions should be given to patents upon discharge\nPregnancy category C",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "allergic reactions",
          "url": "https://wikem.org/wiki/Allergic_reactions"
        },
        {
          "text": "thrombocytopenia",
          "url": "https://wikem.org/wiki/Thrombocytopenia"
        },
        {
          "text": "Serum sickness",
          "url": "https://wikem.org/wiki/Serum_sickness"
        }
      ]
    },
    "See_Also": {
      "text": "Anavip\nSnake bites\nCrotaline (Pit Vipers)\nElapidae (Coral Snakes)",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Anavip",
          "url": "https://wikem.org/wiki/Anavip"
        },
        {
          "text": "Snake bites",
          "url": "https://wikem.org/wiki/Snake_bites"
        },
        {
          "text": "Crotaline (Pit Vipers)",
          "url": "https://wikem.org/wiki/Crotaline_(Pit_Vipers)"
        },
        {
          "text": "Elapidae (Coral Snakes)",
          "url": "https://wikem.org/wiki/Elapidae_(Coral_Snakes)"
        }
      ]
    }
  }
}